Cryoport Inc. (CYRX)
Market Closed
16 Oct, 08:00 PM
$
16. 84
-0.23
-1.3181%
$
874.48M Market Cap
- P/E Ratio
- Div Yield
53,064 Volume
-1.3 Eps
$ 17.07
Previous Close Want to track CYRX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
CYRX closed today lower at $16.84, a decrease of -1.3181% from yesterday's close, completing a monthly increase of 6.8167% or $1.07. Over the past 12 months, CYRX stock gained 73.6598%.
CYRX is not paying dividends to its shareholders.
The last earnings report, released on Apr 30, 2026, exceeded the consensus estimates by 0.1802%. On average, the company has surpassed earnings expectations by 0.0743%, based on the last three reports.
Cryoport Inc. has completed 2 stock splits, with the recent split occurring on May 19, 2015.
The company's stock is traded on 5 different exchanges and in various currencies, with the primary listing on NASDAQ (CM) (USD).
Is CryoPort (CYRX) Outperforming Other Medical Stocks This Year?
Here is how CryoPort, Inc. (CYRX) and Delcath Systems, Inc. (DCTH) have performed compared to their sector so far this year.
Zacks | 2 weeks ago
CryoPort (CYRX) Upgraded to Buy: Here's Why
CryoPort (CYRX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks | 2 months ago
Cryoport, Inc. (CYRX) Q2 2026 Earnings Call Transcript
Cryoport, Inc. (CYRX) Q2 2026 Earnings Call Transcript
Seekingalpha | 2 months ago
Cryoport Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Curtis Ellergodt Rothschild Investment LLC | 375 | $3,022.2 | $6,240 | $3,217.8 | 106.47% |
| JD Jim Dushek HARBOUR INVESTMENTS Inc. | 724 | $45,684.4 | $12,047.36 | -$33,637.04 | -73.63% |
| NA Nizar Araji National Bank Of Canada /FI/ | 7 | $109.9 | $119.49 | $9.59 | 8.73% |
| SN Stephanie Nee HARBOR CAPITAL ADVISORS Inc. | 86,084 | $1.09M | $1.45M | $364,687.04 | 33.59% |
| BG Bart Gancher Intech Investment Management LLC | 10,337 | $67,409.86 | $176,452.59 | $109,042.73 | 161.76% |
Cryoport Inc. (CYRX) FAQ
What is the stock price today?
The current price is $16.84.
On which exchange is it traded?
Cryoport Inc. is listed on NASDAQ (CM).
What is its stock symbol?
The ticker symbol is CYRX.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, the market cap is 874.48M.
Has Cryoport Inc. ever had a stock split?
Cryoport Inc. had 2 splits and the recent split was on May 19, 2015.
Cryoport Inc. Profile
| Air Freight & Logistics Industry | Industrials Sector | Jerrell W. Shelton CEO | NASDAQ (CM) Exchange | 229050307 CUSIP |
| US Country | 688 Employees | - Last Dividend | 5 Feb 2010 Last Split | 15 Mar 2005 IPO Date |
Overview
Cryoport, Inc. is a pivotal player in the temperature-controlled supply chain industry, specializing in solutions for various sectors including biopharma/pharma, animal health, and human reproductive medicine. The company's reach spans across the Americas, Europe, the Middle East, Africa, and the Asia Pacific, making it a global provider. Established in 1999 and headquartered in Brentwood, Tennessee, Cryoport has carved a niche in offering innovative and reliable logistics and storage solutions tailored for the management of temperature-sensitive biological materials.
Products and Services
- Cryoport Express Shippers: Specialized shipping containers designed for the secure and temperature-controlled transport of biological materials.
- Cryoport ELITE -80°C Gene Therapy Shipper: Advanced shipping solution catering specifically to the gene therapy sector, enabling safe transport at extremely low temperatures.
- Cryoport ELITE Cryosphere Shipper: Another variant in the Cryoport ELITE series, these shippers are tailored for shipping materials that require maintenance of specific cold temperatures without the need for external power sources.
- Cryoport Consulting Services: Offers expertise in the qualification of shipping systems, packaging solutions, and the development of custom packaging to meet client-specific needs across various temperature ranges.
- Cryoport Bioservices: Comprehensive suite of services including controlled temperature storage, fulfilment, secondary packaging, and labelling of therapeutic products, alongside GMP raw materials storage services.
- CRYOGENE Services: Specialized in the management of pre-clinical temperature-controlled biological materials encompassing specimen storage, collection, and retrieval processes.
- CRYOPD: Offers a range of temperature-controlled logistics solutions ranging from cryogenic to controlled ambient packaging and transport solutions.
- IntegriCell Services: Focuses on services like apheresis/leukapheresis collection, Cryoshuttle transportation, and cryo-process optimization, catering to the cell and gene therapy sectors.
- MVE Biological Solutions' Fusion Cryogenic System: A self-sustaining cryogenic freezer designed for the secure storage of biological specimens at ultra-low temperatures.
- MVE Biological Solutions' Vario Cryogenic System: Offers flexible temperature management between -20°C and -150°C, addressing a broad spectrum of cryogenic storage needs.
- Cryoport Cryoshuttle: Provides dedicated local transportation support, enhancing the delivery and receipt of sensitive biological materials.
- Tec4Med: Although not elaborated upon, it is indicated as part of Cryoport’s suite of solutions, likely representing a technology-driven service or product within the logistics and cryogenic storage domain.
- Additional Services: Cryoport also offers an array of supplementary services including biological specimen cryopreservation, archiving, monitoring, tracking, receipt, delivery management of samples, and logistics and engineering consulting services.
Contact Information
Address: 112 Westwood Place
Phone: 949 470 2300
Website: https://www.cryoportinc.com
2026 © Marketlog. All Rights Reserved.
